Correlation Between Tokyu REIT and Santen Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Tokyu REIT and Santen Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tokyu REIT and Santen Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tokyu REIT and Santen Pharmaceutical Co, you can compare the effects of market volatilities on Tokyu REIT and Santen Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tokyu REIT with a short position of Santen Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tokyu REIT and Santen Pharmaceutical.
Diversification Opportunities for Tokyu REIT and Santen Pharmaceutical
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tokyu and Santen is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Tokyu REIT and Santen Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Santen Pharmaceutical and Tokyu REIT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tokyu REIT are associated (or correlated) with Santen Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Santen Pharmaceutical has no effect on the direction of Tokyu REIT i.e., Tokyu REIT and Santen Pharmaceutical go up and down completely randomly.
Pair Corralation between Tokyu REIT and Santen Pharmaceutical
If you would invest 137,857 in Tokyu REIT on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Tokyu REIT or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Tokyu REIT vs. Santen Pharmaceutical Co
Performance |
| Timeline |
| Tokyu REIT |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Santen Pharmaceutical |
Tokyu REIT and Santen Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tokyu REIT and Santen Pharmaceutical
The main advantage of trading using opposite Tokyu REIT and Santen Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tokyu REIT position performs unexpectedly, Santen Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Santen Pharmaceutical will offset losses from the drop in Santen Pharmaceutical's long position.| Tokyu REIT vs. Commonwealth Bank of | Tokyu REIT vs. Inter Parfums | Tokyu REIT vs. Arrow Financial | Tokyu REIT vs. PennantPark Floating Rate |
| Santen Pharmaceutical vs. Sanofi ADR | Santen Pharmaceutical vs. Bristol Myers Squibb | Santen Pharmaceutical vs. AstraZeneca PLC ADR | Santen Pharmaceutical vs. Gilead Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |